1. bookVolume 12 (2019): Edition 4 (December 2019)
Détails du magazine
Première parution
19 Jun 2009
4 fois par an
access type Accès libre

The effect of venlafaxine on blood pressure and ECG in rats fed with high-fat-fructose diet

Publié en ligne: 30 Apr 2020
Volume & Edition: Volume 12 (2019) - Edition 4 (December 2019)
Pages: 192 - 199
Reçu: 14 Aug 2019
Accepté: 20 Dec 2019
Détails du magazine
Première parution
19 Jun 2009
4 fois par an

Metabolic syndrome represents one of the major health, social and economic issues nowadays, and affects more than 25% people worldwide. Being a multifactorial health problem, metabolic syndrome clusters various features, such as obesity, dyslipidemia, hyperglycemia and hypertension. Each of these disturbances represents a risk factor for developing cardiovascular disease. Moreover, patients with metabolic syndrome are more likely to suffer from depression, thus treatment with antidepressants (e.g. venlafaxine) is often neccessary. However, many of the antidepressants themselves may contribute to worsening or even development of the metabolic syndrome, thus creating a “vicious circle”. The aim of this work was to investigate on the animal model of metabolic syndrome, i.e. on hypertriacylglycerolemic rats fed high-fat-fructose diet (HFFD): 1) the effect of a change in diet from HFFD to a standard diet (SD) and the effect of venlafaxine treatment, 2) during HFFD, 3) as well as during a changed diet to SD. We focused on biometric parameters, blood pressure and selected ECG parameters. We observed the reversibility of the present metabolic and cardiovascular changes by switching the HFFD to SD in the last 3 weeks of the experiment. Switch to the standard diet led to decrease of body weight, even in the presence of venlafaxine. Administration of venlafaxine caused the decrease of heart weight/body weight index in rats fed with HFFD compared to the untreated group fed with HFFD for 8 weeks. Blood pressure, which was increased in the HFFD group showed a tendency to decrease to control values after switching to the standard diet. Administration of venlafaxine led to significant increase in all parameters of blood pressure when rats were fed with HFFD throughout the whole experiment. In untreated rats fed with HFFD for 8 weeks, we observed a shorter PQ interval and prolonged QRS complex as well as QTc interval compared to untreated rats with diet switched to SD. This effect was potentiated by venlafaxine administered not only during HFFD but even after switch to SD. Our results point to the fact that metabolic syndrome is clearly affecting the function of the cardiovascular system by modifying blood pressure and electrical activity of the heart. Moreover, administration of venlafaxine may lead to worsening of the observed changes, especially in the presence of high-fat-fructose diet.


Abozguia K, Chudley S, Gammage M. (2006). Dose-dependent Venlafaxine-induced sinus tachycardia. Int J Cardiol113: E9–10.Search in Google Scholar

Alosaimi FD, Abalhassan M, Alhaddad B, Alzain N, Fallata E, Alhabbad A, Alassiry MZ. (2017). Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study. Gen Hosp Psychiatry45: 62–69.Search in Google Scholar

Bavle A. (2015). Venlafaxine induced QTc interval prolongation in a therapeutic dose. Asian J Psychiatr16: 63–64.Search in Google Scholar

Bilora F, Vettore G, Barbata A, Pastorello M, Petrobelli F, San Lorenzo I. (1999). Electrocardiographic findings in obese subjects. Minerva Gastroenterol Dietol45: 193–197.Search in Google Scholar

Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA. (2005). Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. J Hypertens23: 1241–9.Search in Google Scholar

Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, Cros G, Azay J. (2005). Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis179: 43–49.Search in Google Scholar

Dupas J, Feray A, Goanvec C, Guernec A, Samson N, Bougaran P, Guerrero F, Mansourati J. (2017). Metabolic Syndrome and Hypertension Resulting from Fructose Enriched Diet in Wistar Rats. Biomed Res Int2017: 2494067.Search in Google Scholar

Elezaby A, Sverdlov AL, Tu VH, Soni K, Luptak I, Qin F, Liesa M, Shirihai OS, Rimer J, Schaffer JE, Colucci WS, Miller EJ. (2015). Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload. J Mol Cell Cardiol79: 275–283.Search in Google Scholar

Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). (2011). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet377: 557–567.Search in Google Scholar

Flegal KM, Graubard BI, Williamson DF, Gail MH. (2007). Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA298: 2028–2037.Search in Google Scholar

Gancheva S, Galunska B, Zhelyazkova-Savova M. (2017). Diets rich in saturated fat and fructose induce anxiety and depression-like behaviors in the rat: is there a role for lipid peroxidation? Int J Exp Pathol98: 296–306.10.1111/iep.12254574378729210119Search in Google Scholar

Gariepy G, Nitka D, Schmitz N. (2010). The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes (Lond)34: 407–419.Search in Google Scholar

Gradel AKJ, Salomonsson M, Sørensen CM, Holstein-Rathlou NH, Jensen LJ. (2018). Long-term diet-induced hypertension in rats is associated with reduced expression and function of small artery SKCa, IKCa, and Kir2.1 channels. Clin Sci (Lond)132: 461–474.Search in Google Scholar

Harvey AT, Rudolph RL, Preskorn SH. (2000). Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry57: 503–509.Search in Google Scholar

Hinderliter AL, Sherwood A, Craighead LW, Lin PH, Watkins L, Babyak MA, Blumenthal JA. (2014). The long-term effects of lifestyle change on blood pressure: One-year follow-up of the ENCORE study. Am J Hypertens 27: 734–741.Search in Google Scholar

Howarth FC, Jacobson M, Shafiullah M, Adeghate E. (2008). Long-term effects of type 2 diabetes mellitus on heart rhythm in the Goto-Kakizaki rat. Exp Physiol93: 362–369.Search in Google Scholar

Cheng S-M, Cheng Y-J, Wu L-Y, Kuo C-H, Lee Y-S, Wu M-C, Huang C-Y, Ting H, Lee S-D. (2014). Activated apoptotic and anti-survival effects on rat hearts with fructose induced metabolic syndrome. Cell Biochem Funct32: 133–141.Search in Google Scholar

Jover B, Reynes C, Rugale C, Reboul C, Jeanson L, Tournier M, Lajoix AD, Desmetz C. (2017). Sodium restriction modulates and prevents cardiac remodeling in a rat model of Metabolic syndrome. Biochim Biophys Acta Mol Basis Dis1863: 1568–1574.Search in Google Scholar

Kaprinay B, Lipták B, Slovák L, Švík K, Knezl V, Sotníkoví R, Gáspárová Z. (2016). Hypertriglyceridemic rats fed high fat diet as a model of metabolic syndrome. Physiol Res65: S515–S518.Search in Google Scholar

Kaprinay B, Gáspárová Z, Lipták B, Frimmel K, Sotníková R. (2017). Endothelial dysfunction in experimental models of metabolic syndrome - effect of fructose. Eur Pharm J64: 4–6.Search in Google Scholar

Khalifa M, Daleau P, Turgeon J. (1999). Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther291: 280–284.Search in Google Scholar

Khurana RN, Baudendistel TE. (2003). Hypertensive crisis associated with venlafaxine. Am J Med115: 676–677.Search in Google Scholar

Kıvrak Y, Güvenç TS, Akbulut N, Yağcı I, Çığşar G, Gündüz S, Balcı B. (2014). Accelerated Hypertension after Venlafaxine Usage. Case Rep Psychiatry2014: 659715.Search in Google Scholar

Knezl V, Sotní ková R, Brnoliaková Z, Stankovič ová T, Bauer V, Bezek Š. (2017). Monotherapy of experimental metabolic syndrome: II. study of cardiovascular effects. Interdiscip Toxicol10: 86–92.Search in Google Scholar

Kurl S, Laaksonen DE, Jae SY, Makikallio TH, Zaccardi F, Kauhanen J, Ronkainen K, Laukkanen JA. (2015). Metabolic syndrome and the risk of sudden cardiac death in middle-aged men. Int J Cardiol203: 792–797.Search in Google Scholar

Letsas K, Korantzopoulos P, Pappas L, Evangelou D, Efremidis M, Kardaras F. (2006). QT interval prolongation associated with venlafaxine administration. Int J Cardiol109: 116–117.Search in Google Scholar

Li W, Bai Y, Sun K, Xue H, Wang Y, Song X, Fan X, Song H, Han Y, Hui R. (2009). Patients with metabolic syndrome have prolonged corrected QT interval (QTc). Clin Cardiol32: E93–99.Search in Google Scholar

Lipták B, Kaprinay B, Gáspárová Z. (2017a). A rat-friendly modification of the non-invasive tail-cuff to record blood pressure. Lab Animal46: 251–253.10.1038/laban.127228530692Search in Google Scholar

Mbaya P, Alam F, Ashim S, Bennett D. (2007). Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder. Human Psychopharmacology22: 129–133.Search in Google Scholar

McIntyre RS, Young Park K, Law CWY, Sultan F, Adams A, Lourenco MT, Lo AKS, Soczynska JK, Woldeyohannes H, Alsuwaidan M, Yoon J, Kenedy SH. (2010). The association between conventional antidepressants and the metabolic syndrome. CNS Drugs24: 741–753.Search in Google Scholar

Moro C, Cosío FG. (1980). Electrophysiologic study of patients with short P-R interval and normal QRS complex. Eur J Cardiol11: 81–90.Search in Google Scholar

Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB. (2012). Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35: 1171–1180.Search in Google Scholar

Sasváriová M, Tyukos-Kaprinay B, Salvaras L, Belovičová K, Bögi E, Knezl V, Barteková M, Stankovičová T, Dubovický M. (2018). Effect of pre-gestational stress and prenatal venlafaxine administration on cardiovascular system of rat offspring. Eur Pharm J65: 17–22.Search in Google Scholar

Schumacher K, Büttner P, Dagres N, Sommer P, Dinov B, Hindricks G, Bollmann A, Kornej J. (2018). Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation. PLoS One13: e0206933.Search in Google Scholar

Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, Kessler RC. (2006). Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry63: 824–830.Search in Google Scholar

Toscano AE, Amorim MA, de Carvalho Filho EV, Aragão Rda S, Cabral-Filho JE, de Moraes SR, Manhaes-de-Castro R. (2008). Do malnutrition and fluoxetine neonatal treatment program alterations in heart morphology? Life Sci82: 21–22.10.1016/j.lfs.2008.03.01318445498Search in Google Scholar

van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P. (2011). Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res92: 10–18.Search in Google Scholar

Vicen M, Gulač P, Stankovičová T. (2016). Changes in electrical activity of heart during ischemic-reperfusion injury modified by the administration of antidepressants. Eur Pharm J1: 5–8.Search in Google Scholar

Vancampfort D, Correll CU, Wampers M, Sienaert P, Mitchaell AJ, De Herdt A, Probst M, Scheewe W, De Hert M. (2014). Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalence and moderating variables. Psychol Med44: 2017–2028.Search in Google Scholar

Watanabe H., Tanabe N, Watanabe T, Roden D M, Sasaki S. (2008). Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation. Circulation117: 1255–1260.Search in Google Scholar

Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. (2018). The Effects of a Modified High-carbohydrate High-fat Diet on Metabolic Syndrome Parameters in Male Rats. Exp Clin Endocrinol Diabetes 126: 205–212.Search in Google Scholar

Yang Q, Kiyoshige K, Fujimoto T, Katayama M, Fujino K, Saito K, Nakaya Y, Mori H. (1990). Signal-averaging electrocardiogram in patients with diabetes mellitus. Jpn Heart J31: 25–33.Search in Google Scholar

Yilmaz H1, Özcan KS, Sayar N, Kemaloglu T, Gungor B, Erer B, Yilmaz M, Gurkan U, Cakmak N, Oz D, Calik AN, Bolca O. (2015). Metabolic syndrome is associated with atrial electrical and mechanical dysfunction. Med Princ Pract24: 147–152.Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo